Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Tonstad

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 28, 2018
Associations between persistent organic pollutants and metabolic syndrome in morbidly obese individualsS Dusanov, J Ruzzin, H Kiviranta, et al.
Journal of Internal Medicine|March 1, 1997
Molecular genetics of familial hypercholesterolaemia in NorwayT P Leren, S Tonstad, K E Gundersen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 20, 1997
[Application of gene technology in the diagnosis of familial hypercholesterolemia]T P Leren, K S Bakken, O K Rødningen, et al.
Journal of Human Hypertension|January 20, 2012
Kiwifruit decreases blood pressure and whole-blood platelet aggregation in male smokersA Karlsen, M Svendsen, I Seljeflot, et al.
European Journal of Clinical Investigation|July 17, 2004
8-isoprostane increases scavenger receptor A and matrix metalloproteinase activity in THP-1 macrophages, resulting in long-lived foam cellsH Scholz, P Aukrust, J K Damås, et al.
Diabetologia|July 8, 2005
Tesaglitazar, a novel dual peroxisome proliferator-activated receptor alpha/gamma agonist, dose-dependently improves the metabolic abnormalities associated with insulin resistance in a non-diabetic populationB Fagerberg, S Edwards, T Halmos, et al.
European Journal of Clinical Pharmacology|January 1, 1994
The effect of the gastrointestinal lipase inhibitor, orlistat, on serum lipids and lipoproteins in patients with primary hyperlipidaemiaS Tonstad, D Pometta, D W Erkelens, et al.
European Heart Journal|April 26, 2003
Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised studyS Tonstad, C Farsang, G Klaene, et al.
International Journal of Obesity (2005)|February 17, 2010
A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose studyL J Aronne, S Tonstad, M Moreno, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|February 4, 2016
Development of composite outcomes for individual patient data (IPD) meta-analysis on the effects of diet and lifestyle in pregnancy: a Delphi surveyE Rogozinska, M I D'Amico, K S Khan, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 28, 2018
Associations between persistent organic pollutants and metabolic syndrome in morbidly obese individualsS Dusanov, J Ruzzin, H Kiviranta, et al.
Journal of Internal Medicine|March 1, 1997
Molecular genetics of familial hypercholesterolaemia in NorwayT P Leren, S Tonstad, K E Gundersen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 20, 1997
[Application of gene technology in the diagnosis of familial hypercholesterolemia]T P Leren, K S Bakken, O K Rødningen, et al.
Journal of Human Hypertension|January 20, 2012
Kiwifruit decreases blood pressure and whole-blood platelet aggregation in male smokersA Karlsen, M Svendsen, I Seljeflot, et al.
European Journal of Clinical Investigation|July 17, 2004
8-isoprostane increases scavenger receptor A and matrix metalloproteinase activity in THP-1 macrophages, resulting in long-lived foam cellsH Scholz, P Aukrust, J K Damås, et al.
Diabetologia|July 8, 2005
Tesaglitazar, a novel dual peroxisome proliferator-activated receptor alpha/gamma agonist, dose-dependently improves the metabolic abnormalities associated with insulin resistance in a non-diabetic populationB Fagerberg, S Edwards, T Halmos, et al.
European Journal of Clinical Pharmacology|January 1, 1994
The effect of the gastrointestinal lipase inhibitor, orlistat, on serum lipids and lipoproteins in patients with primary hyperlipidaemiaS Tonstad, D Pometta, D W Erkelens, et al.
European Heart Journal|April 26, 2003
Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised studyS Tonstad, C Farsang, G Klaene, et al.
International Journal of Obesity (2005)|February 17, 2010
A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose studyL J Aronne, S Tonstad, M Moreno, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|February 4, 2016
Development of composite outcomes for individual patient data (IPD) meta-analysis on the effects of diet and lifestyle in pregnancy: a Delphi surveyE Rogozinska, M I D'Amico, K S Khan, et al.
Pageof 11